The group’s principle activities include designing, develop and market revolutionary proprietary technology for radiation shielding applications, and to launch a range of products incorporating this technology for temporary or permanent use. The group also provides practice of radiation oncology and makes it easily available and accessible to all patients. The group operates from United States.
